Simultaneous Determination of Atenolol and Chlorthalidone in Pharmaceutical Preparations by Capillary-Zone Electrophoresis

Abstract

A capillary zone electrophoresis (CZE) method for the simultaneous determination of the β-blocker drugs atenolol and chlorthalidone in pharmaceutical formulations has been developed. The CZE separation was performed under the following conditions: capillary temperature, 25°C; applied voltage, 25 kV; 20 mM H₃PO₄–NaOH running buffer (pH 9.0); and detection wavelength, 198 nm. Phenobarbital was used as internal standard. The method was validated and showed not only good precision and accuracy but also good robustness. The method has been successfully applied to the simultaneous determination of both atenolol and chlorthalidone in pharmaceutical tablets.     

Indirect Determination of Organic Compounds by Atomic Absorption Spectrophotometry: The Study of Vitamin B12 in Pharmaceutical Dosage Forms

Abstract

A method for the determination of vitamin B₁₂ in pharmaceutical dosage forms is presented. The method involves, dissolution of the vitamin B₁₂ and subsequent determination of the complexed cobalt by atomic absorption spectrophotometry. The method is both rapid and sensitive giving applications to quality, control of this type of formulation.     

Spectrophotometric Study of Acid-Base Equilibrium of a Thienotriazolodiazepine,Brotizolam, Determination in Pharmaceutical Formulations

Abstract

Brotizolam is a psychotropic drug, derived from the Thieno-triazolodiazepine family, which has sedative and hypnotic properties. In this work, a spectrophotometric study has been carried out to determine the acid-base equilibrium, the pk_a value being obtained, as well as to develop a method for the determination of this compound in pharmaceutical formulations.     

High‐Performance Liquid Chromatography Determination of Latanoprost in Pharmaceutical Formulations using UV Detection

Abstract

A simple, fast, and accurate high‐performance liquid chromatography (HPLC) method was developed to determine latanoprost in pharmaceutical formulations. The drug was chromatographed on a C₁₈ column. Eluents were monitored at a wavelength of 210 nm using a mixture of acetonitrile and 0.05 M potassium phosphate buffer pH 3.0 (70:30, (v/v). A linear response (r>0.9998) was observed in the range of 10.0–90.0 µg mL^?1. The method showed good recoveries (average 100.4%) and the relative standard deviations intra‐ and inter‐day were ≤1.0%. The method can be used for quality control assay of latanoprost in raw materials as well as in pharmaceutical formulations.     

A Rapid Isocratic Reversed-Phase Separation and Determination of Some Barbiturates by High-Performance Liquid Chromatography

Abstract

A high performance liquid chromatographic method for the rapid separation and quantitative determination of five barbiturates in pharmaceutical preparations and body fluids has been developed. A C₁₈ reversed phase column was used and the barbiturates were detected at 235nm.

A number of eluting systems were examined, the most suitable of them being, Ethanol:Propanol:Methanol:Water (26:5:29:40) at pH = 8.8.     

Determination of Riboflavin Using Flow Injection Inhibitory Chemiluminescence

ABSTRACT

A new flow injection method for the determination of riboflavin based on the inhibition of the intensity of chemiluminescence (CL) from the luminol-K₃Fe(CN)₆ system is described. While riboflavin mixed with K₃Fe(CN)₆, by the fast oxidation reaction between riboflavin and K₃Fe(CN)₆, K₄Fe(CN)₆ was generated, which then inhibited the CL reaction of K₃Fe(CN)₆ and luminol in alkaline aqueous solution. The CL emission was correlated with the riboflavin concentration in the range from 0.032 to 100 μg·ml?¹, and the detection limit was 0.01 μg·ml?¹ (3σ). A complete analysis could be performed in 2 min with a relative standard deviation of less than 2.2%. The influence of foreign species was studied and the method has been applied successfully to the determination of riboflavin in pharmaceutical samples, the recovery was from 98.0% to 102%.     

Simultaneous Quantitation of Minoxidil and Tretinoin in Magistral and Pharmaceutical Preparations by First Derivative Spectrophotometry

Abstract

A first derivative spectrophotometry method has been developed for the simultaneous quantitation of minoxidil and tretinoin. The method is based on measuring the first derivative signals (D₁) of minoxidil and tretinoin at 290 and 351 nm, respectively, without any interference from each other, or any other coexisting materials. Beer's law was valid over the concentration range 2–10 μg/ml of minoxidil and 0.25–1.25 μg/ml of tretinoin. The proposed method has been applied successfully to the determination of some magistral and pharmaceutical preparations. Relative standard deviations for the assay of both drugs were less than 0.95%.     

FT‐IR Spectrophotometric Analysis of Chromium (Tris) Picolinate and its Pharmaceutical Formulations

Abstract

A Fourier transform infrared (FT‐IR) spectrometric method was developed for the rapid, direct measurement of chromium (tris) picolinate [Cr(pic)₃] in different pharmaceutical products. Conventional KBr potassium bromine spectra were compared for best determination of active substance in drug preparations. Lambert‐Beer's law and two chemometric approaches, partial least squares (PLS) and principal component regression (PCR+) methods, were used in data processing.     

High‐Performance Liquid Chromatographic Determination of Parecoxib in Human Plasma and Pharmaceutical Formulations

Abstract

A simple and sensitive RP‐HPLC method for the determination of parecoxib (PXB) in human plasma and pharmaceutical formulations has been developed and validated. The separation of PXB and the internal standard, ibuprofen (IBF) was achieved on a CLC C₁₈ (5 μ, 25 cm×4.6 mm i.d.) column using UV detector at 200 nm. The mobile phase consisted of acetonitrile‐water (92:8 v/v). The linear range of detection was found to be 0.9–18.4 µg/ml (r=0.9985). Intra‐ and inter‐day assay relative standard deviations were observed to be less than 0.3%. The method has been applied successfully for the determination of PXB in spiked human plasma and pharmaceutical preparations. Analytical parameters were calculated and complete statistical evaluation is incorporated.     

Electrochemical Behavior of 6-Mercapto-Purine at Hanging Copper Amalgam Dropping Electrode and Its Trace Determination by Differential Pulse Adsorption Cathodic Stripping Voltammetry

Abstract

The electrochemical behavior of 6-MP was studied by cyclic voltammetry at a hanging copper amalgam dropping electrode (HCADE). It was found that 6-MP could form a complex with the Cu(II) stripped from the HCADE, showing a new peak at ?0.19V in the medium of 0.1mol/L LiClO₄-0.5mol/L HClO₄ solution. The mechanism of the reaction was proposed. This new peak was sensitive and could be used for the determination of trace 6-MP by differential pulse adsorption cathodic stripping voltammetry (DPAdCSV). The linear range was from 3.6×10^?10 to 5.3×10^?6 mol/L, and the detection limit was about 1.2×10^?10 mol/L (S/N=3). The method was also successfully applied to the determination of 6-MP in pharmaceutical tablets.     

Extraction - Spectrophotometric Determination of Phosphate Using N-Phenylbenzohydroxamic Acid

Abstract

A simple solvent extraction and spectrophotometric method for the determination of micro amount of phosphate (PO₄) is described. Phosphate is selectively separated from associated elements by reacting it with calcium and extracting excess calcium with N-phenylbenzohydroxamic acid (PBHA) at pH 11.3. The excess calcium was determined in ultra-violet and visible region and hence the phosphate content was calculated. The Beer's law is obeyed in the range 0.5 ? 10.0 ppm at 340 nm and 0.25 - 8.0 ppm at 560 nm of phosphate for a fixed amount of calcium (20.0 ppm). These results are also compared with those obtained by atomic absorption spectrophotometry. The method has been applied for the determination of phosphate in pharmaceutical and other samples.     

Optimization,Validation and Application of a Capillary Zone Electrophoresis Method for the Assay of Sparfloxacin in Pharmaceutical Formulation

Abstract

A capillary zone electrophoresis (CZE) method has been developed for the determination of the antibiotic sparfloxacin in tablets. The CZE separation was performed using 75 µm×35 cm fused-silica capillary under the following conditions: 25°C; applied voltage, 12 kV; 25 mM H₃PO₄-NaOH running buffer (pH 8.5). The detection wavelength was 254 nm. Flumequine was used as internal standard (IS). The method was suitably validated with respect to linearity, limit of detection and quantification, accuracy, precision, specificity, and robustness. The calibration was linear from 10 to 60 µg mL^?1 and the limit of detection and quantification were 5.38 and 9.46 µg mL^?1, respectively. Recoveries ranging from 95.68%–102.4% were obtained in the determination of sparfloxacin that were spiked to placebos. Excipients in the commercial tablets and degraded products from different stress conditions did not interfere in the assay. The method was successfully applied to the determination of sparfloxacin in pharmaceutical tablets.     

Determination of vitamin B<Subscript>12</Subscript> using a chemiluminescence flow system

A method to determine vitamin B₁₂ by measuring the chemiluminescence (CL) intensities using a flow injection (FI) system has been proposed. It is based on the catalytic effect of cobalt(II) in vitamin B₁₂ on the CL reaction between luminol and hydrogen peroxide in a basic medium. The increment of the CL intensity is proportional to the concentration of vitamin B₁₂ in the range 8.68–86.9 ng/mL (r ² = 0.9984) with a detection limit (3σ) of 0.89 ng/mL. The CL response is obtained in 10 s at a flow rate of 3.0 mL/min with a relative standard deviation (RSD) of less than 2.5% (n = 6). The method has been successfully applied to the determination of vitamin B₁₂ in pharmaceutical injections. The text was submitted by the authors in English.     

Validated Assay for the Determination of Mitoxantrone in Pharmaceuticals Using Capillary Zone Electrophoresis

Abstract

The first capillary zone electrophoretic (CZE) method for the determination of mitoxantrone (MTX) in pharmaceutical formulations was developed. The influence of background electrolyte (BGE) species, pH, concentration (c _BGE), organic modifier, capillary temperature, applied voltage, and injection time was investigated. Optimum results were achieved with 25 mM ammonium acetate at an apparent pH value of 5.0 in 50% v/v acetonitrile, applied voltage of +30 kV, and capillary temperature of 25°C. The samples were introduced into the capillary hydrodynamically for 2 s at 33.5 mbar. Mitoxantrone was detected at a wavelength of 242 nm. Mitoxantrone and doxorubicin (DOX) (used as internal standard, ISTD) were completely separated in less than 7 min. The method was suitably validated with respect to linearity, limits of detection (LOD) and quantification (LOQ), accuracy, precision, selectivity, and robustness. The proposed method was applied successfully for the determination of MTX in its injectable pharmaceutical formulation.     

Indirect Determination of Lidocaine by Atomic Absorption Spectrophotometry

Abstract

A new procedure for determining lidocaine chlorhydrate is described. The method consists of extracting an ion pair composed of Lidocaine and the inorganic complex Co(SCN)₄ ^2- into an organic solvent (1, 2 dichloroethane), then measure the Co in the organic phase by A.A.S. at 240.7 mm. Optimal experimental conditions concerning pH, Co(SCN)₄ ^?2 concentration, shaking time, phase ratio, number of extractions and linear range for calibration are studied. The method has a standard deviation of 10^?2. Two pharmaceutical preparations containing lidocaine, have been analyzed with very good results.     

Indirect Determination of Bromhexine by Atomic Absorption Spectrophotometry

Abstract

A new procedure for determination of Bromohexine is described. The method consists of extracting an ion pair between the Bromhexine and the inorganic complex Co(SCN)² ₄ and measuring Co in the organic phase by AAS at 240. 7 nm. The optimal experimental conditions: pH, concentration of Co(SCN)² ₄, shaking time, phase ratio, number of extractions and the linear range of calibration are studied.

The organic phase used is 1,2-dichloroethane. The standard deviation of the method is 10^?3. The interference of foreign substances which accompany the Bromhexine in pharmaceutical preparations is studied, and the method is applied to their quantitative determination in medicines.     

Development and Validation Method for Silica Determination by Spectrophotometry in Some Herbs and Pharmaceutical Formulations

ABSTRACT

A spectrophotometric method for determination of silica in herbs and herbal pharmaceutical products has been developed and validated. The method showed excellent accuracy and precision with S.D. 1.67 and RSD 1.72%, 2.75%, respectively. The established linearity range was 0.05–0.5 μg/mL(r² > 0.99974). The recovery of silica from spiked placebo was > 95% over the linear range. The method has been successfully used in the analysis of silica in raw material and herbal pharmaceutical formulations. This validated method proved to be rapid and less costly.     

Use of Second Derivative Spectrophotometry For the Determination of Certain Cephalosporins and Their Acid-Induced Degradation Products In Combination

Abstract

Methods for determination of individual cephalosporins and their corresponding acid-induced degradation products are described, based upon second derivative spectrophotometry. Linear plots of D₂[dbnd](d²A/dλ²) values with negligible intercept were obtained versus concentration in the range of 0.4–2.4 mg% for both intact and degraded cephalosporins. Kinetic investigation of the cephalosporins degradation proved that the proposed method is applicable to stability determinations Compared with the official method the assay results of the different cephaiosporins pharmaceutical preparations were of equal accuracy (t-test) and reproducibility (F-test).     

RP‐HPLC Method for the Determination of Tenofovir in Pharmaceutical Formulations and Spiked Human Plasma

Abstract

A simple reverse‐phase high‐performance liquid chromatographic method for the determination of tenofovir disoproxil fumarate (TDF) in pharmaceutical formulations and human plasma samples has been developed and validated. Piroxicam (PRX) was used as an internal standard. The assay of the drug was performed on a CLC C₁₈ (5 μ, 25 cm×4.6 mm i.d.) with UV detection at 259 nm. The mobile phase consisted of acetonitrile–water mixture in the ratio of 75∶25, and a flow rate of 1 ml/min was maintained. The standard curve was linear over the range of 0.2–10 µg/ml (r ²=0.9966). Analytic parameters have been evaluated. Within‐day and between‐day precision as expressed by relative standard deviation was found to be less than 2%. The method has been applied successfully for the determination of TDF in spiked human plasma samples and pharmaceutical formulations.     

The Determination of Perphenazine by a New Simple Flow‐Injection Chemiluminescence Method

Abstract

A rapid and simple flow‐injection chemiluminescence (CL) method is described for the determination of perphenazine, which is based on the CL intensity that generated from the redox reaction of Ce (IV)-perphenazine in HNO₃ medium is proportional to the perphenazine concentration without any sensitizers. The proposed method allows the determination range within 1.0×10^?7–7.0 ×10^?5 g mL^?1 with a detection limit of 8.0×10^?8 g mL^?1, and it has been successfully applied to the determination of the perphenazine in pharmaceutical tablet compared well with the official method.